Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 30;11(8):1074.
doi: 10.3390/cancers11081074.

The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis

Stephen P Ducray  1 , Karthikraj Natarajan  2 , Gavin D Garland  1 , Suzanne D Turner  3 , Gerda Egger  4   5
Affiliations
Review

The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis

Stephen P Ducray et al. Cancers (Basel). .

Abstract

Anaplastic lymphoma kinase (ALK) is a tyrosine kinase involved in neuronal and gut development. Initially discovered in T cell lymphoma, ALK is frequently affected in diverse cancers by oncogenic translocations. These translocations involve different fusion partners that facilitate multimerisation and autophosphorylation of ALK, resulting in a constitutively active tyrosine kinase with oncogenic potential. ALK fusion proteins are involved in diverse cellular signalling pathways, such as Ras/extracellular signal-regulated kinase (ERK), phosphatidylinositol 3-kinase (PI3K)/Akt and Janus protein tyrosine kinase (JAK)/STAT. Furthermore, ALK is implicated in epigenetic regulation, including DNA methylation and miRNA expression, and an interaction with nuclear proteins has been described. Through these mechanisms, ALK fusion proteins enable a transcriptional programme that drives the pathogenesis of a range of ALK-related malignancies.

Keywords: ALCL; ALK; ALK-translocation proteins; EML4-ALK; NPM-ALK; NSCLC; epigenetics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The Nucleophosmin 1 (NPM1)-ALK fusion protein resulting from the t(2;5)(p23;q25). Fusion of the NPM1 gene on chromosome 5 to the ALK gene on chromosome 2 results in the expression of NPM1-ALK, a constitutively activate tyrosine kinase. NPM1 encodes an oligomerisation domain (residues 1–117), a metal binding domain (MB; residues 104–115), two acidic amino acid clusters (AC: D and E amino acid rich domains which function as acceptor regions for nucleolar targeting signals; residues 120–132 and 161–188) and two nuclear localisation signals (NLS; residues 152–157 and 191–197). ALK encodes a Meprin/A5/protein tyrosine phosphatase domain (not shown), a ligand-binding site (residues 391–401) in the extracellular domain, a lipophilic transmembrane region (TM) and an intracellular domain that contains the tyrosine-kinase catalytic domain (TKD).
Figure 2
Figure 2
The NPM1-ALK fusion protein signals through the Janus protein tyrosine kinase (JAK)/STAT, Ras/mitogen-activated protein kinases (MAPK), phosphatidylinositol 3-kinase (PI3K)/Akt and phospholipase C gamma (PLC-γ) pathways. Adapted from Trigg et al., 2018 [23].
Figure 3
Figure 3
The NPM1-ALK fusion protein drives epigenetic change through DNA methyltransferase (DNMT), miRNA, and transcription factor (TF) expression and through interacting with nuclear proteins.
See this image and copyright information in PMC

References

    1. Morris S.W., Kirstein M.N., Valentine M.B., Dittmer K.G., Shapiro D.N., Saltman D.L., Look A.T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science. 1994;263:1281–1284. doi: 10.1126/science.8122112. - DOI - PubMed
    1. Iwahara T., Fujimoto J., Wen D., Cupples R., Bucay N., Arakawa T., Mori S., Ratzkin B., Yamamoto T. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene. 1997;14:439–449. doi: 10.1038/sj.onc.1200849. - DOI - PubMed
    1. Bischof D., Pulford K., Mason D.Y., Morris S.W. Role of the nucleophosmin (NPM) portion of the non-Hodgkin’s lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol. Cell. Biol. 1997;17:2312–2325. doi: 10.1128/MCB.17.4.2312. - DOI - PMC - PubMed
    1. Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., Fujiwara S., Watanabe H., Kurashina K., Hatanaka H., et al. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448:561–566. doi: 10.1038/nature05945. - DOI - PubMed
    1. Colleoni G.W.B., Bridge J.A., Garicochea B., Liu J., Filippa D.A., Ladanyi M. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35) Am. J. Pathol. 2000;156:781–789. doi: 10.1016/S0002-9440(10)64945-0. - DOI - PMC - PubMed

LinkOut - more resources